CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (1,386,168)	$ (3,896,270)
Adjustments to reconcile net loss to net cash used by operating activities:
Stock based compensation	56,533	11,450
Restricted stock	156,400	0
Amortization of debt issue costs	305,800	43,750
Depreciation and amortization	71,276	44,935
Issuance of stock / warrants for services	627,825	0
Other-than-temporary impairment on marketable securities	175,000	0
Debt conversion expense	446,250	0
Inventory impairment	67,226	0
Accounts receivable impairment	50,000	0
Loss on sale of property and equipment	4,000	0
Common stock issued as charitable contribution	17,000	225,000
Non-cash consideration received for services provided	(1,932,552)	0
Changes in operating assets and liabilities:
Accounts receivable and accounts receivable other	(39,928)	(163,823)
Accounts receivable and accounts receivable other- related party	(750,064)	0
Inventory	(41,216)	(519,740)
Prepaid inventory	0	374,820
Prepaid expenses and other current assets	58,458	78,266
Accounts payable and accrued expenses	(745,252)	785,916
Accounts payable and accrued expenses - related party	278,265	0
Interest Payable	184,889	110,442
Deferred Revenue	41,417	0
Deferred tax liability	25,000	8,000
Cash used by operating activities	(2,329,841)	(2,897,254)
Cash flows from investing activities:
Proceeds from sale of investments to a related party	200,000	0
Deferred initial public offering costs	(39,723)	0
Purchase of property and equipment	(7,967)	(127,259)
Cash used by investing activities	152,310	(127,259)
Cash flows from financing activities:
Proceeds from issuance of common stock	829,497	1,984,747
Exercise of stock options	3,002	0
Debt issuance cost	(200,800)	0
Proceeds from convertible note	2,125,000	0
Proceeds from line of credit	0	1,782,814
Distribution related party	(29,180)	0
Repayments of line of credit	(300,000)	(1,165,173)
Repayment of note payable shareholder	0	(90,078)
Cash provided by financing activities	2,427,519	2,512,310
Net (decrease) increase in cash	249,988	(512,203)
Cash and cash equivalents, beginning of year	34,258	546,461
Cash and cash equivalents, end of year	284,246	34,258
Cash Payments for:
Interest expense	5,210	1,293
Non-cash financial activities:
Common stock issued for financing fees	0	105,000
Common stock issued to purchase membership interest – I’M1	971,667	0
Common stock issued to purchase membership interest – EE1	471,668	0
Non-controlling interest transfer	950,242	0
Strike price adjustment on placement agent warrants	31,350	0
Common stock issued for warrant exercise	38	0
Common Stock issued for conversion of Line of Credit	773,177	0
Common Stock issued for conversion of Promissory Notes	2,252,500	0
Deferred IPO costs acquired via issuance of payables	362,817	0
Deferred IPO costs acquired via issuance of stock/warrants	95,195	0
Distributions of stock to non-controlling interests	223,440	0
Stock and warrants issued for intangible assets	379,714	0
Fixed assets acquired through lease	14,983	0
Non-cash proceeds on sale of fixed assets	7,000	0
Intellectual property issued via issuance of payables	$ 945,000	$ 0